Proactive Investors - Run By Investors For Investors

G Medical Innovations board member buys $107,791 worth of out-of-the-money options

The options have a 30-cent strike price and expire 1 May 2020.
nasdaq sign
The company recently gained SEC approval for a NASDAQ listing

G Medical Innovations Holdings Ltd (ASX:GMV) non-executive director Brendan de Kauwe has purchased 2.5 million unlisted options for $107,791.

The options have a 30-cent exercise price, well above the last traded price of 19 cents and expire 1 May 2020.

For these options to have value, the share price must be above 30 cents before this date.

READ: G Medical Innovations releases prospectus for NASDAQ listing after obtaining SEC approval

Earlier this week, G Medical released its prospectus detailing a dual-listing on the NASDAQ Capital Market.

The company proposes to raise a minimum of US$17 million through the offer of American Depositary Shares (ADS).

The executives of the company will commence a US investor roadshow on 3 June 2019, after the mandatory exposure period concludes.

View full GMV profile View Profile

G Medical Innovations Holdings Ltd Timeline

Related Articles

Partnered married couple
July 15 2019
DomaCom launched an equity release product for Australian seniors in June that allows investors to buy part of their property.
Greenhouse full  of plants
February 01 2019
The global marijuana market is projected to reach an eye-watering US$58.90 billion between 2018 and 2023
Video conference call
June 14 2019
The company’s core software-as-a-service product aims to make audio conferencing simpler, and more productive
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use